Literature DB >> 20053251

Use of the visual analog scale to rate and monitor severity of nausea in the emergency department.

Robert Meek1, Anne-Maree Kelly1, Xue Feng Hu1.   

Abstract

OBJECTIVES: The objective was to describe the association between verbal descriptors of nausea severity and visual analog scale (VAS) ratings in an undifferentiated emergency department (ED) population and to calculate the minimum clinically significant difference (MCSD) in VAS rating of nausea severity in this population.
METHODS: A prospective observational study was conducted at three EDs on a convenience sample of stable, consenting adult patients presenting with nausea as part of their symptom complex. Data included demographics, adjectival description of nausea severity (none, mild, moderate, or severe), and VAS rating (standard 100-mm line) at enrollment, 30 minutes, and 60 minutes. At 30 and 60 minutes they were also asked to describe any change in nausea severity from the previous rating ("a lot less,""a little less,""the same,""a little more,""a lot more"). The MCSD was defined as the average VAS change when a patient reported "a little less" or "a little more" nausea.
RESULTS: A total of 247 patients provided 693 matched adjectival ratings and VAS scores. Median age was 45 years, and 100 (40%) were male. The median VAS measures for none, mild, moderate, and severe nausea were 2, 23, 53, and 83 mm, respectively. VAS distributions in the verbal categories were statistically different from each other (Spearman rank correlation coefficient = 0.90; p < 0.0001). The MCSD was 22 mm (95% CI = 20 to 24 mm).
CONCLUSIONS: There is very good correlation between verbal descriptors of nausea and VAS ratings. The MCSD for VAS nausea ratings in an ED population is 22 mm.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20053251     DOI: 10.1111/j.1553-2712.2009.00581.x

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  8 in total

1.  The effect of CYP2D6 drug-drug interactions on hydrocodone effectiveness.

Authors:  Andrew A Monte; Kennon J Heard; Jenny Campbell; D Hamamura; Richard M Weinshilboum; Vasilis Vasiliou
Journal:  Acad Emerg Med       Date:  2014-08-24       Impact factor: 3.451

2.  A randomized trial of olanzapine versus palonosetron versus infused ondansetron for the treatment of breakthrough chemotherapy-induced nausea and vomiting in patients undergoing hematopoietic stem cell transplantation.

Authors:  Midori Nakagaki; Michael Barras; Cameron Curley; Jason P Butler; Glen A Kennedy
Journal:  Support Care Cancer       Date:  2016-10-13       Impact factor: 3.603

3.  Foot Reflexology: An Intervention for Pain and Nausea Among Inpatients With Cancer.

Authors:  Kristen D Anderson; Marty Downey
Journal:  Clin J Oncol Nurs       Date:  2021-10-01       Impact factor: 1.283

Review 4.  Prophylactic antiemetics for adults receiving intravenous opioids in the acute care setting.

Authors:  Michael Gottlieb; Jestin N Carlson; Gary D Peksa
Journal:  Cochrane Database Syst Rev       Date:  2022-05-19

5.  The Longitudinal Parallel Process Analysis of Biomarkers of Oxidative Stress, Symptom Clusters, and Cognitive Function in Children With Leukemia.

Authors:  Mary C Hooke; Daniel Hatch; Marilyn J Hockenberry; Susan Whitman; Ida Moore; David Montgomery; Kari Marano; Pauline Mitby; Michael E Scheurer; Olga Taylor; Wei Pan
Journal:  J Pediatr Oncol Nurs       Date:  2020-03-06       Impact factor: 1.636

6.  The effects of body position on chemotherapy-induced nausea and vomiting: a single-blind randomized controlled trial.

Authors:  Mohammad Fathi; Alireza Nikbakht Nasrabadi; Sina Valiee
Journal:  Iran Red Crescent Med J       Date:  2014-06-05       Impact factor: 0.611

7.  Effects of Preoperative Oral Electrolyte-Carbohydrate Nutrition Supplement on Postoperative Outcomes in Elderly Patients Receiving Total Knee Arthroplasty: A Prospective Randomized Controlled Trial.

Authors:  Yue He; Xiumei Tang; Ning Ning; Jiali Chen; Peifang Li; Pengde Kang
Journal:  Orthop Surg       Date:  2022-08-30       Impact factor: 2.279

8.  The use of ondansetron for the treatment of nausea in dogs with vestibular syndrome.

Authors:  S Foth; S Meller; H Kenward; J Elliott; L Pelligand; H A Volk
Journal:  BMC Vet Res       Date:  2021-06-21       Impact factor: 2.741

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.